Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» rociletinib
rociletinib
Racing AstraZeneca, Clovis gets a speedy FDA review for its lung cancer drug
Fierce Biotech
Wed, 09/30/15 - 04:43 pm
AstraZeneca
Clovis Oncology
FDA
rociletinib
lung cancer
5 Big FDA Decisions Expected in August
24/7 Wall St
Thu, 08/6/15 - 02:58 pm
FDA
Exelixis
vemurafenib
aripiprazole lauroxil
Alkermes
evolocumab
Amgen
Bristol-Myers Squibb
Opdivo
Clovis Oncology
rociletinib
Clovis Wins One ASCO '15 Battle, Loses Another, Against Rival AstraZeneca
TheStreet.com
Mon, 06/1/15 - 09:41 am
Clovis Oncology
ASCO
rucaparib
AstraZeneca
Lynparza
rociletinib
AZD9291
Clovis Lung Cancer Update Swings Momentum to Rival, Slightly
TheStreet.com
Wed, 11/19/14 - 10:08 am
Clovis Oncology
AstraZeneca
rociletinib
lung cancer
Clovis taps GlaxoSmithKline to team up on lung cancer
Fierce Biotech
Tue, 11/18/14 - 11:51 am
Clovis
GSK
non-small cell lung cancer
Mekinist
rociletinib
Clovis Shares Higher on Improved Outlook for Lung Cancer Drug
TheStreet.com
Mon, 09/29/14 - 06:41 pm
Clovis Oncology
lung cancer
AZD9291
rociletinib
Pages
« first
‹ previous
1
2